Intuit Inc header image

Intuit Inc

INTU

Equity

ISIN US4612021034 / Valor 60141

NASDAQ (2024-09-18)
USD 633.07-1.82%

Intuit Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Intuit Inc. is a financial software company known for its popular products such as QuickBooks, TurboTax, and Credit Karma. The company provides a range of financial management solutions for individuals and small businesses, helping them with tasks such as accounting, tax preparation, and credit monitoring. Intuit's software products are designed to simplify financial processes and improve overall financial health for its users.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (07.08.2024):

Revenue Growth

Intuit Inc. reported a significant increase in total revenue for the third quarter of fiscal 2024, which ended on April 30. The company achieved a total revenue of $6.7 billion, marking a 12 percent growth compared to the same period last year. This growth was driven by strong performances across various business segments, including the Consumer Group and the Small Business and Self-Employed Group.

Consumer Group Performance

In the third quarter of fiscal 2024, Intuit Inc.'s Consumer Group revenue grew to $3.7 billion, reflecting a 9 percent increase from the previous year. The company expects TurboTax Live revenue to grow by 17 percent for the full fiscal year, reaching approximately $1.4 billion. This growth is attributed to an increase in average revenue per return and a rise in TurboTax Live units.

Small Business and Self-Employed Group

The Small Business and Self-Employed Group of Intuit Inc. saw a robust revenue growth of 18 percent in the third quarter of fiscal 2024, reaching $2.4 billion. The Online Ecosystem revenue within this segment also increased by 19 percent, driven by growth in payments, payroll, and Mailchimp offerings. QuickBooks Online Accounting revenue grew by 19 percent, supported by customer growth and higher effective prices.

Credit Karma Revenue

Intuit Inc.'s Credit Karma segment reported a revenue of $443 million for the third quarter of fiscal 2024, an 8 percent increase from the previous year. This growth was driven by strong performances in Credit Karma Money, credit cards, auto insurance, and personal loans. The segment's positive results contributed to the overall financial performance of the company.

Forward-looking Guidance

Intuit Inc. has raised its guidance for the full fiscal year 2024, expecting total revenue to be between $16.164 billion and $16.200 billion, representing a growth of approximately 13 percent. The company also anticipates GAAP operating income to grow by 21 to 22 percent, reaching between $3.815 billion and $3.835 billion. Non-GAAP diluted earnings per share are expected to be between $16.79 and $16.84, reflecting a growth of approximately 17 percent.

Summarized from source with an LLMView Source

Key figures

18.3%1Y
12.7%3Y
136%5Y

Performance

26.9%1Y
37.1%3Y
37.2%5Y

Volatility

Market cap

180738 M

Market cap (USD)

Daily traded volume (Shares)

383,017

Daily traded volume (Shares)

1 day high/low

644.74 / 632.1

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Ascendis Pharma
Ascendis Pharma Ascendis Pharma Valor: 26912602
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.56%USD 148.88
Halozyme Therapeutics Inc
Halozyme Therapeutics Inc Halozyme Therapeutics Inc Valor: 1814799
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.61%USD 62.31
ASML Holding NV
ASML Holding NV ASML Holding NV Valor: 19531091
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.52%EUR 715.00
CCC Intelligent Solutions Holdings Inc
CCC Intelligent Solutions Holdings Inc CCC Intelligent Solutions Holdings Inc Valor: 112930391
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.46%USD 10.82
Weibo Corp
Weibo Corp Weibo Corp Valor: 23986224
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.08%USD 7.51
CyberArk Software Ltd
CyberArk Software Ltd CyberArk Software Ltd Valor: 24786540
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.79%USD 268.04
TEMENOS LTD
TEMENOS LTD TEMENOS LTD Valor: 1245391
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%CHF 60.00
PIERER Mobility AG
PIERER Mobility AG PIERER Mobility AG Valor: 41860974
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.79%CHF 25.20
ALSO Holding AG
ALSO Holding AG ALSO Holding AG Valor: 2459027
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.19%CHF 267.00
SoftwareOne Holding Ltd.
SoftwareOne Holding Ltd. SoftwareOne Holding Ltd. Valor: 49645150
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%CHF 15.42